registration report part a - anses.fr · the company oxon italia spa has requested marketing...

27
Part A National Assessment - Country FRANCE SIP 40972 (PERSEO) Page 1 of 27 Registration Report Southern Zone Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26 REGISTRATION REPORT Part A Risk Management Product code: SIP 40972 Product name(s): PERSEO Active Substance(s): Azoxystrobin, 68 g/L Chlorothalonil, 233 g/L COUNTRY: FRANCE Southern Zone Zonal Rapporteur Member State: France NATIONAL ASSESSMENT FRANCE (marketing authorisation) Applicant: Oxon Italia SpA Date: 2017-09-26

Upload: vophuc

Post on 21-Aug-2018

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 1 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

REGISTRATION REPORT

Part A

Risk Management

Product code: SIP 40972

Product name(s): PERSEO

Active Substance(s):

Azoxystrobin, 68 g/L

Chlorothalonil, 233 g/L

COUNTRY: FRANCE

Southern Zone

Zonal Rapporteur Member State: France

NATIONAL ASSESSMENT FRANCE

(marketing authorisation)

Applicant: Oxon Italia SpA

Date: 2017-09-26

Page 2: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 2 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Table of Contents

1 DETAILS OF THE APPLICATION ...................................................................................................................... 3

1.1 APPLICATION BACKGROUND ................................................................................................................................... 3 1.2 ACTIVE SUBSTANCE APPROVAL ................................................................................................................................ 3 1.3 REGULATORY APPROACH ....................................................................................................................................... 4 1.4 DATA PROTECTION CLAIMS .................................................................................................................................... 5 1.5 LETTER(S) OF ACCESS ........................................................................................................................................... 5

2 DETAILS OF THE AUTHORISATION ................................................................................................................ 6

2.1 PRODUCT IDENTITY .............................................................................................................................................. 6 2.2 CLASSIFICATION AND LABELLING .............................................................................................................................. 6

2.2.1 Classification and labelling under Directive 99/45/EC .......................................................................... 6 2.2.2 Classification and labelling in accordance with Regulation (EC) No1272/2008 .................................... 6 2.2.3 Other phrases in compliance with Regulation (EU) No 547/2011 ......................................................... 7 2.2.4 Other phrases linked to the preparation ............................................................................................... 7

2.3 PRODUCT USES .................................................................................................................................................... 8

3 RISK MANAGEMENT.................................................................................................................................... 10

3.1 REASONED STATEMENT OF THE OVERALL CONCLUSIONS TAKEN IN ACCORDANCE WITH THE UNIFORM PRINCIPLES .................. 10 3.1.1 Physical and chemical properties ........................................................................................................ 10 3.1.2 Methods of analysis ............................................................................................................................ 10 3.1.3 Mammalian Toxicology ....................................................................................................................... 11 3.1.4 Residues and Consumer Exposure ....................................................................................................... 12 3.1.5 Environmental fate and behaviour ...................................................................................................... 14 3.1.6 Ecotoxicology....................................................................................................................................... 14 3.1.7 Efficacy ................................................................................................................................................ 16

3.2 CONCLUSIONS ARISING FROM FRENCH ASSESSMENT ................................................................................................. 17 3.3 SUBSTANCES OF CONCERN FOR NATIONAL MONITORING ............................................................................................ 17 3.4 FURTHER INFORMATION TO PERMIT A DECISION TO BE MADE OR TO SUPPORT A REVIEW OF THE CONDITIONS AND RESTRICTIONS

ASSOCIATED WITH THE AUTHORISATION ........................................................................................................................... 17 3.4.1 Post-authorisation monitoring ............................................................................................................ 17 3.4.2 Post-authorisation data requirements ................................................................................................ 17 3.4.3 Label amendments .............................................................................................................................. 17

APPENDIX 1 – COPY OF THE FRENCH DECISION .................................................................................................... 18

APPENDIX 2 – COPY OF THE DRAFT PRODUCT LABEL AS PROPOSED BY THE APPLICANT ...................................... 22

APPENDIX 3 – LETTER(S) OF ACCESS ..................................................................................................................... 27

Page 3: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 3 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

PART A – Risk Management

The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO

(formulation code: SIP 40972), containing 68 g/L azoxystrobin and 233 g/L chlorothalonil for use as a fungicide.

The risk assessment conclusions are based on the information, data and assessments provided in Registration

Report, Part B Sections 1-7 and Part C, and where appropriate the addenda for France. The information, data and

assessments provided in Registration Report, Part B include assessment of further data or information as required at

national registration by the EU peer review. It also includes assessment of data and information relating to PERSEO

(SIP 40972) where those data have not been considered in the EU peer review process. Otherwise assessments for

the safe use of PERSEO (SIP 40972) have been made using endpoints agreed in the EU peer review of both

azoxystrobin and chlorothalonil.

This document describes the specific conditions of use and labelling required for France for the registration of

PERSEO (SIP 40972).

Appendix 1 of this document provides a copy of the French Decision.

Appendix 2 of this document is a copy of the draft product label as proposed by the applicant.

Appendix 3 of this document is a copy of the letter(s) of Access.

1 DETAILS OF THE APPLICATION

1.1 Application background

The present registration report concerns the evaluation of Oxon Italia SpA’s application to market PERSEO (SIP

40972) in France as a fungicide (product uses described under point 2.3). France acted as a zonal Rapporteur

Member State (zRMS) for this request and assessed the application submitted for the first authorisation of this

product in France and in other MSs of the Southern zone.

1.2 Active substance approval

Azoxystrobin

Commission Implementing Regulation (EU) No 703/2011 of 20 July 2011 approving the active substance

azoxystrobin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council

concerning the placing of plant protection products on the market, and amending the Annex to Commission

Implementing Regulation (EU) No 540/2011.

Specific provisions of Regulation (EU) No 703/2011 were as follows :

PART A

Only uses as fungicide may be authorised.

PART B

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009,

the conclusions of the review report on azoxystrobin and in particular Appendices I and II thereof, as finalised in

the Standing Committee on the Food Chain and Animal Health on 17 June 2011 shall be taken into account.

In this overall assessment Member States shall pay particular attention to:

(1) the fact that the specification of the technical material as commercially manufactured must be confirmed and

supported by appropriate analytical data. The test material used in the toxicity dossiers should be compared and

verified against this specification of the technical material;

(2) the potential for groundwater contamination, when the active substance is applied in regions with vulnerable

soil and/or climatic conditions;

(3) the protection of aquatic organisms.

Page 4: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 4 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

The Member States must ensure that the conditions of authorisation include risk mitigation measures, where

appropriate.

The Member States concerned shall request the submission of confirmatory information as regards the risk

assessment on groundwater and aquatic organisms.

The notifier shall submit to the Member States, the Commission and the Authority such information by 31

December 2013.

An EFSA conclusion is available (EFSA Journal 2010; 8(4): 1542).

A Review Report is available (SANCO/11027/2011 rev 3, 20 March 2015).

Chlorothalonil

Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No

1107/2009 of the European Parliament and of the Council as regards the list of approved active substances.

Specific provisions of Regulation (EU) No 540/2011 were as follows :

PART A

Only uses as fungicide may be authorised.

PART B

For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009,

the conclusions of the review report on chlorothalonil, and in particular Appendices I and II thereof, as finalised in

the Standing Committee on the Food Chain and Animal Health on 15 February 2005 shall be taken into account.

In this overall assessment Members States must pay particular attention to the protection of:

(1) aquatic organisms,

(2) groundwater, in particular with regards to the active substance and its metabolites R417888 and R611965

(SDS46851), when the substance is applied in regions with vulnerable soil and/or climate conditions.

Conditions of use should include risk mitigation measures, where appropriate.

There is no EFSA Conclusion on the peer review of the pesticide risk assessment of the active substance.

A Review Report is available (SANCO/4343/2000 final (revised), 28 September 2006).

1.3 Regulatory approach

The present application (2013-1208 ) was evaluated in France by the French Agency for Food, Environmental and

Occupational Health & Safety (Anses)1 in the context of the zonal procedure for all Member States of the Southern

zone, taking into account the worst-case uses (“risk envelope approach”)2 – the highest application rates over the

Southern Zone. When risk mitigation measures were necessary, they are adapted to the situation in France.

According to the French law and procedures, specific conditions of use are set out in the Decision letter.

The French Order of 4th May 2017 3 provides that:

- unless formally stated in the product authorisation, the pre harvest interval (PHI) is at least three days;

- unless formally stated in the product authorisation, the minimum buffer zone alongside a water body is five

metres;

- unless formally stated in the product authorisation, the minimum re-entry period is six hours for field uses and

eight hours for indoor uses.

Drift reduction measures such as low-drift nozzles are not considered within the decision-making process in France.

1 French Food Safety Agency, Afssa, before 1 July 2010 2 SANCO document “risk envelope approach”, European Commission (14 March 2011). Guidance document on the preparation and

submission of dossiers for plant protection products according to the “risk envelope approach”; SANCO/11244/2011 rev. 5 3 https://www.legifrance.gouv.fr/eli/arrete/2017/5/4/AGRG1632554A/jo/texte

Page 5: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 5 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

However, drift buffer zones may be reduced under some circumstances as explained in Appendix 3 of the above-

mentioned French Order.

The current document (RR) based on Anses’s assessment of the application submitted for this product is in

compliance with Regulation (EC) no 1107/20094, implementing regulations, and French regulations.

The data taken into account are those deemed to be valid either at European Union level or at zonal/national level.

This part A of the RR presents a summary of essential scientific points upon which recommendations are based and

is not intended to show the assessment in detail.

The conclusions relating to the acceptability of risk are based on the criteria indicated in Regulation (EU)

No 546/20115, and are expressed as “acceptable” or “not acceptable” in accordance with those criteria.

Finally, the French Order of 26 March 20146 provides that:

- an authorisation granted for a “reference” crop applies also for “linked” crops, unless formally stated in the

Decision

- the “reference” and “linked” crops are defined in Appendix 1 of that French Order.

Thus, at French national level, possible extrapolation of submitted data and the corresponding assessment from

“reference” crops to “linked” ones are undertaken even if not clearly requested by the applicant in their dRR, and a

conclusion is reached on the acceptability of the intended uses on those “linked” crops. The aim of this Order,

mainly based on the EU document on residue data extrapolation7 is to supply “minor” crops with registered plant

protection products.

Therefore the GAP table (Section 2.3) and Decision may include uses on crops not originally requested by the

applicant.

The Decision, as reproduced in Appendix 1, takes also into account national provisions, including national

mitigation measures.

1.4 Data protection claims

Where protection for data is being claimed for information supporting registration of PERSEO (SIP 40972), it is

indicated in the reference lists in Appendix 1 of the Registration Report, Part B Sections 1-7.

1.5 Letter(s) of Access

The applicant has provided equivalent studies to the original applicant’s Annex II dossier.

Additionally, the applicant has provided supporting data in Document K; the ownership of the data is indicated in

the reference lists in Appendix 1 of the Registration Report, Part B Sections 1-7. A copy of the letter(s) of access is

reproduced in Part A, Appendix 3.

4 REGULATION (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant

protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC 5 COMMISSION REGULATION (EU) No 546/2011 of 10 June 2011 implementing Regulation (EC) No 1107/2009 of the European

Parliament and of the Council as regards uniform principles for evaluation and authorisation of plant protection products 6 http://www.legifrance.gouv.fr/eli/arrete/2014/3/26/AGRG1407093A/jo 7 SANCO document “guidance document:- Guidelines on comparability, extrapolation, group tolerances and data requirements for setting

MRLs”: SANCO/ 7525/VI/95 - rev.9

Page 6: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 6 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

2 DETAILS OF THE AUTHORISATION

2.1 Product identity

Product name (code) PERSEO (SIP 40972)

Authorisation number Not applicable

Function Fungicide

Applicant Oxon Italia SpA

Composition 68 g/L azoxystrobin

233 g/L chlorothalonil

Formulation type (code) Suspension concentrate (SC)

Packaging HDPE bottle (1 L), HDPE cans (5 L, 10 L, 20 L)

2.2 Classification and labelling

2.2.1 Classification and labelling under Directive 99/45/EC

Not applicable after 1st June 2015.

2.2.2 Classification and labelling in accordance with Regulation (EC) No1272/2008

Physical hazards -

Health hazards Skin Sens. 1A, STOT SE 3, Acute Tox. 4, Carc. Cat. 2

Environmental

hazards

Aquatic Acute 1; Aquatic Chronic 1

Hazard pictograms

Signal word Warning

Hazard statements H317 May cause an allergic skin reaction.

H332 Harmful if inhaled.

H335 May cause respiratory irritation.

H351 Suspected of causing cancer.

H400 Very toxic to aquatic life

H410 Very toxic to aquatic life with long lasting effects.

Precautionary

statements –

For the P phrases, refer to the extant legislation

Supplementary

information (in

accordance with

Article 25 of

Regulation (EC) No

1272/2008)

- -

See Part C for justifications of the classification and labelling proposals.

Page 7: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 7 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

2.2.3 Other phrases in compliance with Regulation (EU) No 547/2011

N/A: not registered in France

2.2.4 Other phrases linked to the preparation

N/A: not registered in France

Page 8: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 8 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

2.3 Product uses

Please note: The GAP Table below reports the intended uses proposed by the applicant, and possible extrapolation according to French Order of 26 March 2014 (highlighted in green), evaluated and concluded as safe

uses by France as zRMS. Those uses are then granted in France.

When the conclusion is “not acceptable”, the intended use is highlighted in grey and the main reason(s) reported in the remarks. When a use is “acceptable” with GAP restrictions, the modifications of the GAP are in bold.

Use should be crossed out when the applicant no longer supports this use.

GAP rev.1, date: 2017-09-26

PPP (product name/code): PERSEO (SIP 40972) Formulation type: <GCPF code> (a, b)

Active substance 1: Azoxystrobin Conc. of as 1: 68 g/L (c)

Active substance 2: Chlorothalonil Conc. of as 2: 233 g/L (c)

Applicant: Oxon Italia SpA Professional use:

Zone(s): Southern (d) Non professional use:

Verified by MS: Yes

Field of use: Fungicide

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Use-

No. (e)

Member

state(s)

Crop and/

or situation

(crop destination /

purpose of crop)

F,

Fn,

Fpn

G,

Gn,

Gpn

or

I

Pests or Group of pests

controlled

(additionally:

developmental stages of the pest or pest group)

Application Application rate PHI (days)

Remarks: e.g. g

safener/synergist per

ha (f)

Method /

Kind

Timing / Growth

stage of crop &

season

Max. number

a) per use

b) per crop/ season

Min. interval

between

applications (days)

L product / ha

a) max. rate per

appl. b) max. total

rate per

crop/season

kg as/ha

a) max. rate per appl.

b) max. total

rate per crop/season

Water

L/ha

min /

max

Zonal uses (field or outdoor uses, certain types of protected crops)

1 FR Wheat, triticale F Septoria tritici,

Puccinia recondita, Puccinia striiformis,

Septoria nodorum

Spray BBCH 31-69 a) 2

b) 2

14 a) 3

b) 6

a) AZO 0.204;

CTN 0.699 b) AZO 0.408;

CTN 1.398

200 -

300 56 Not acceptable

(groundwater contamination)

2 FR Rye F Puccinia recondita Spray BBCH 31-69 a) 2

b) 2

14 a) 3

b) 6

a) AZO 0.204;

CTN 0.699

b) AZO 0.408; CTN 1.398

200 -

300

56 Not acceptable

(groundwater

contamination)

3 FR Barley F Pyrenophora teres, Puccinia hordei,

Rhynchosporium secalis

Ramularia collo-cygni

Spray BBCH 31-59 a) 1 b) 1

Not

applicable

a) 3 b) 3

a) AZO 0.204; CTN 0.699

b) AZO 0.204;

CTN 0.699

200 - 300

F Not acceptable

(groundwater

contamination)

Page 9: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 9 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Remarks

table

heading:

(a) e.g. wettable powder (WP), emulsifiable concentrate (EC), granule (GR)

(b) Catalogue of pesticide formulation types and international coding system CropLife International Technical Monograph n°2, 6th Edition Revised May 2008

(c) g/kg or g/l

(d) Select relevant

(e) Use number(s) in accordance with the list of all intended GAPs in Part B, Section 0 should be given in column 1

(f) No authorization possible for uses where the line is highlighted in grey, Use should be crossed

out when the notifier no longer supports this use.

Remarks

columns:

1 Numeration necessary to allow references

2 Use official codes/nomenclatures of EU Member States 3 For crops, the EU and Codex classifications (both) should be used; when relevant, the use

situation should be described (e.g. fumigation of a structure)

4 F: professional field use, Fn: non-professional field use, Fpn: professional and non-

professional field use, G: professional greenhouse use, Gn: non-professional greenhouse

use, Gpn: professional and non-professional greenhouse use, I: indoor application

5 Scientific names and EPPO-Codes of target pests/diseases/ weeds or, when relevant, the common names of the pest groups (e.g. biting and sucking insects, soil born insects, foliar

fungi, weeds) and the developmental stages of the pests and pest groups at the moment of

application must be named. 6 Method, e.g. high volume spraying, low volume spraying, spreading, dusting, drench

Kind, e.g. overall, broadcast, aerial spraying, row, individual plant, between the plants -

type of equipment used must be indicated.

7 Growth stage at first and last treatment (BBCH Monograph, Growth Stages of Plants, 1997,

Blackwell, ISBN 3-8263-3152-4), including where relevant, information on season at time of application

8 The maximum number of application possible under practical conditions of use must be provided.

9 Minimum interval (in days) between applications of the same product

10 For specific uses other specifications might be possible, e.g.: g/m³ in case of fumigation of empty

rooms. See also EPPO-Guideline PP 1/239 Dose expression for plant protection products.

11 The dimension (g, kg) must be clearly specified. (Maximum) dose of a.s. per treatment (usually g, kg or L product / ha).

12 If water volume range depends on application equipments (e.g. ULVA or LVA) it should be

mentioned under “application: method/kind”. 13 PHI - minimum pre-harvest interval

14 Remarks may include: Extent of use/economic importance/restrictions

Page 10: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 10 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

3 RISK MANAGEMENT

3.1 Reasoned statement of the overall conclusions taken in accordance with the Uniform Principles

3.1.1 Physical and chemical properties

The formulation PERSEO (SIP 40972) is a suspension concentrate. All studies have been performed in accordance

with the current requirements and the results are deemed to be acceptable. The appearance of the product is that of

homogeneous whitish water-based liquid formulation with characteristic odour. It is not explosive and has no

oxidizing properties. The product has no flash point below 100°C. It has a self-ignition temperature over 604°C. In

1% aqueous solution, it has a pH value 7.1 at 20°C. There is no effect of low and high temperature on the stability of

the formulation, since after 7 days at 0°C and 14 days at 54°C, neither the active ingredient content nor the technical

properties were changed. The stability data indicate a shelf life of at least 2 years at ambient temperature when

stored in HDPE packaging. Nevertheless, the content of relevant impurity of azoxystrobin (Z-isomer) in the

formulation must be determined before and after storage. The persistent foam was not determined after 2-year

storage; as the results are acceptable after 14 days at 54°C, no further data is required. Its technical characteristics

are acceptable for a suspension concentrate formulation.

The formulation is not classified for the physical-chemical part.

3.1.2 Methods of analysis

Azoxystrobin

Analytical methods for the determination of active substance and the relevant impurity (Z-isomer of azoxystrobin)

in the formulation are available and validated. As the relevant impurity toluene is by-products of the manufacturing

process for azoxystrobin and as such cannot be formed by storage of the formulation, an analytical method for the

determination of this relevant impurity in the formulation is not necessary.

Analytical methods are available in the monograph and this dossier and validated for the determination of residues

of azoxystrobin in plants (cereals), food of animal origin, soil, water (surface and drinking) and air.

Chlorothalonil

Analytical method for the determination of active substance in the formulation is available and validated.

As the relevant impurities HCB and DCB are by-products of the manufacturing process for chlorothalonil and as

such cannot be formed by storage of the formulation, an analytical method for the determination of these relevant

impurities in the formulation is not necessary.

Analytical methods are available in the monograph/this dossier and validated for the determination of residues of

chlorothalonil in plants (cereals), food of animal origin, soil, water (surface and drinking) and air.

Nevertheless, it should be provided at the renewal of the active substance a confirmatory method for the

determination of chlorothalonil and its metabolite SDS 3701 in soil.

The active substance is very toxic (T+), therefore an analytical method is available in this dossier and validated for

the determination of residues of chlorothalonil in tissues and body fluids.

Page 11: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 11 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

3.1.3 Mammalian Toxicology

Endpoints used in risk assessment

Active Substance: azoxystrobin

ADI 0.2 mg kg bw/d EU agreed endpoint

ARfD Not applicable EU agreed endpoint

AOEL 0.2 mg/kg bw/d EU agreed endpoint

Dermal absorption According to the guidance on dermal absorption (Efsa 2012)

Concentrate

(used in formulation)

68 g/L

Spray dilution

(used in formulation)

0.68 g/L

Dermal absorption endpoints % 25 75

Active Substance: chlorothalonil

ADI 0.015 mg kg bw/d EU agreed endpoint

ARfD 0.6 mg/kg bw/d EU agreed endpoint

AOEL 0.009 mg/kg bw/d EU agreed endpoint

Dermal absorption Based on an expert judgement on several dermal absorption study with chlorothalonil:

Concentrate

(used in formulation)

233 g/L

Spray dilution

(used in formulation)

2.33 g/L

Dermal absorption endpoints % 1 10

3.1.3.1 Acute Toxicity

PERSEO (SIP 40972) containing 68 g/L of azoxystrobin and 233 g/L of chlorothalonil has a low toxicity in respect

to acute oral, and dermal toxicity and is irritating to the rabbit skin but not to the rabbit eye and is a skin sensitizer.

PERSEO (SIP 40972) is classified with fatal if inhaled by calculation.

3.1.3.2 Operator Exposure

Summary of critical use patterns (worst cases):

Crop F/G8 Equipment

Application rate

L product/ha

(g as/ha)

Spray

dilution

(L/ha)

Model

Cereals F Tractor

mounted/trailed

boom sprayer :

hydraulic nozzles

3L/ha

(204 g/ha of azoxystrobin pure

or 208 g/ha of technical

azoxystrobin and 699 g/ha of

chlorothalonil pure or 709.65

g/ha of technical

chlorothalonil)

200-300 BBA

8 Open field or glasshouse.

Page 12: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 12 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Considering proposed uses, operator systemic exposure was estimated using the German BBA model:

Crop Equipment PPE and/or working coverall % AOEL

azoxystrobin

% AOEL

chlorothalonil

Cereals

Tractor

mounted/trailed

boom sprayer :

hydraulic

nozzles

Working coverall and gloves during mixing/loading

and application 7.6 67

According to the model calculations, it can be concluded that the risk for the operator using PERSEO (SIP 40972) is

acceptable with a working coverall (90% protection factor) and gloves during mixing/loading and application.

For details of personal protective equipment for operators, refer to the Decision in Appendix 1.

3.1.3.3 Bystander Exposure

Bystander exposure was assessed according to EUROPOEM II. Exposure is estimated to 0.55 % of the AOEL of

azoxystrobin and 7% of the AOEL of chlorothalonil.

It is concluded that there is no unacceptable risk to the bystander after incidental short-term exposure to PERSEO

(SIP 40972).

Residential exposure was assessed (according to BFR model). Exposure is estimated to 0.05% and 0.07% of the

AOEL of azoxystrobin and 3.5% and 6.9% of the AOEL of chlorothalonil for adults and children, respectively.

It is concluded that there is no unacceptable risk of residential exposure or to the bystander after incidental short-

term exposure to PERSEO (SIP 40972).

3.1.3.4 Worker Exposure

Workers may have to enter treated areas after treatment for crop inspection activities. Therefore, estimation of

worker exposure was calculated according to EUROPOEM II. Exposure is estimated to 3.9 % of the AOEL of

azoxystrobin and 39% of the AOEL of chlorothalonil.

It is concluded that without taking into account a re-entry period, there is no unacceptable risk anticipated for

workers wearing a working coverall and gloves, when re-entering crops treated with PERSEO (SIP 40972).

For details of personal protective equipment for workers, refer to the Decision in Appendix 1.

3.1.4 Residues and Consumer Exposure

Overall conclusion

The data available are considered sufficient for risk assessment. An exceedance of the current MRLs of for

azoxystrobin and chlorothalonil as laid down in Reg. (EU) 396/2005 is not expected.

The chronic and the short-term intakes of azoxystrobin and chlorothalonil residues are unlikely to present a public

health concern.

As far as consumer health protection is concerned, Anses, France agrees with the authorization of the intended

use(s).

According to available data, the following specific mitigation measures are recommended:

A PHI of 56 days on wheat should be respected.

Summary of the evaluation

The preparation PERSEO (SIP 40972) is composed of azoxystrobin and chlorothalonil.

Page 13: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 13 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Summary for azoxystrobin

Crop

Plant

metabolism

covered?

Sufficient

residue

trials?

PHI

sufficiently

supported?

Sample

storage

covered

by

stability

data?

MRL

compliance

Reg

11973/2014

Chronic risk

for

consumers

identified?

Acute risk

for

consumers

identified?

Wheat Yes Yes (9 NEU

+ 9 SEU) Yes Yes Yes

No

No

Barley Yes Yes (8 NEU

+ 9 SEU) yes yes Yes No

Primary crop metabolism of azoxystrobin was sufficiently investigated to define residue for enforcement and risk

assessment in crops under consideration.

Regarding the magnitude of residues in those crops, a sufficient number of residue trials are available to support all

the intended GAPs in France. These data allowed to estimate the expected residue concentrations in the relevant

plant commodities, and to confirm that no MRL exceedance will result from intended uses.

The effects of processing on the nature of azoxystrobin residues have been investigated.

Residues in succeeding crops have been sufficiently investigated taking into account the specific circumstances of

the cGAP uses being considered here. It is very unlikely that residues will be present in succeeding crops.

Considering dietary burden and based on the intended uses, no significant modification of the intake was calculated

for livestock. Further investigation of residues as well as the modification of MRLs in commodities of animal origin

is therefore not necessary.

Summary for chlorothalonil

Crop

Plant

metabolism

covered?

Sufficient

residue

trials?

PHI

sufficiently

supported?

Sample

storage

covered

by

stability

data?

MRL

compliance

Reg

1146/2014

Chronic

risk for

consumers

identified?

Acute risk

for

consumers

identified?

Comments

Wheat Yes Yes (9 NEU

+ 8 SEU) Yes Yes Yes

No

No With a PHI

of 56 days

Barley Yes

Yes (14

NEU + 8

SEU)

yes yes Yes No

For wheat, 17 trials evaluated in the monography are available to support the intended GAP (with a PHI of 56 days

in northern Europe). 16 additional trials have been submitted. However they have been performed according to more

critical GAP than the intended one (application until BBCH 85 with a PHI of 35 days) and the MRL may be

exceeded in northern Europe. Therefore a PHI of 56 days is needed in France.

The effects of processing on the nature of residues have been investigated. Data on effects of processing on the

amount of residue have been submitted. These data were not considered for risk assessment. Validation data of

analytical methods used for chlorothalonil in barley processing study are required in post-authorisation.

Residues in succeeding crops have been sufficiently investigated taking into account the specific circumstances of

the cGAP uses being considered here. It is very unlikely that residues will be present in succeeding crops.

Page 14: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 14 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Considering dietary burden and based on the intended uses, no significant modification of the intake was calculated

for livestock. Further investigation of residues as well as the modification of MRLs in commodities of animal origin

is therefore not necessary.

Summary for PERSEO (SIP 40972)

Crop PHI for Product code

proposed by applicant

PHI/ Withholding period* sufficiently supported for PHI for Product code

proposed by zRMS Azoxystrobin Chlorothalonil

Wheat, rye,

triticale 35 days 35 days 56 days 56 days

Barley 35 days 35 days F** F

* Purpose of withholding period to be specified

** F: PHI is defined by the application stage at last treatment (time elapsing between last treatment and harvest of the crop).

Waiting period before planting succeeding crops

Not required.

3.1.5 Environmental fate and behaviour

The fate and behaviour in the environment have been evaluated according to the requirements of Regulation (EC)

No 1107/2009. Appropriate endpoints from the EU conclusions were used to calculate PEC values for the active

substances and their metabolites for the intended use patterns. In cases where deviations from the EU agreed

endpoints were considered appropriate (for example when additional studies are provided), such deviations were

highlighted and justified accordingly.

The PEC of azoxystrobin, chlorothalonil and their metabolites in soil, surface water and groundwater have been

assessed according to FOCUS guidance documents, with standard FOCUS scenarios to obtain outputs from the

FOCUS models, and the endpoints established in the EU conclusions or agreed in the assessment based on new data

provided.

PEC soil and PECsw derived for the active substances and their metabolites are used for the ecotoxicological risk

assessment, and mitigation measures are proposed.

PECgw for the active substances and their metabolites (except R417888) do not occur at levels exceeding those

mentioned in regulation EC 1107/2009 and guidance document SANCO 221/20009.

PECgw for the metabolite R417888 of chlorothalonil occur at levels exceeding those mentioned in regulation

EC 1107/2009 and guidance document SANCO 221/2000.

Therefore, an unacceptable risk of groundwater contamination cannot be excluded for the intended uses.

Based on vapour pressure, information on volatilisation from plants and soil, and DT50 calculation, no significant

contamination of the air compartment is expected for the intended uses.

3.1.6 Ecotoxicology

3.1.6.1 Effects on Terrestrial Vertebrates

Birds

The risk to birds for the formulated product PERSEO (SIP 40972) (Azoxystrobin 68 g/L + Chlorothalonil 233 g/L

SC), the active substances and chlorothalonil metabolite SDS-3701 was assessed following the provisions of the

EFSA Guidance document on risk assessment for Birds and Mammals.

9 Guidance document on the assessment of the relevance of metabolites in groundwater of substances regulated under Council

directive 91/414/EEC. Sanco/221/2000-rev10-final, 25 February 2003.

Page 15: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 15 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

The acute risk to birds present TERA values above the trigger at screening step, demonstrating an acceptable acute

risk for birds after application of PERSEO (SIP 40972) according to the intended GAP uses.

The reproductive risk assessment was carried out for the two active ingredients and chlorothalonil metabolite SDS-

3701. The results indicate acceptable risk at Tier 1 assessment for both active ingredients and metabolite SDS-3701.

An acceptable risk for birds is expected following consumption of contaminated drinking water or via secondary

poisoning.

Mammals

The risk to mammals for the formulated product PERSEO (SIP 40972), the active substances and chlorothalonil

metabolite SDS-3701 was assessed following the provisions of the EFSA Guidance document on risk assessment for

Birds and Mammals.

The acute risk to mammals present TERA values above the trigger at screening step or Tier-1, demonstrating an

acceptable acute risk for mammals after application of PERSEO (SIP 40972) according to the intended GAP uses.

At Tier 1 long-term risk assessment, a potential risk was identified for omnivorous mammals exposed to the

metabolite SDS-3701 and for herbivorous mammals exposed to chlorothalonil and its metabolite SDS-3701. The

refined long-term TER values for mammals exposed to chlorothalonil and its metabolite SDS-3701 demonstrated an

acceptable risk for omnivorous and herbivorous mammals according to the intended GAP uses.

An acceptable risk for mammals was expected following consumption of contaminated drinking water or via

secondary poisoning.

3.1.6.2 Effects on Aquatic Species

Insert summary of the data/risk assessment for aquatic species.

The risk assessments demonstrate that the risk to aquatic organisms is acceptable following use of PERSEO (SIP

40972) according to the proposed use pattern when considering the following mitigation measures.

Aquatic application mitigation

Proposed Use Mitigation required for protection of the aquatic environment

Spring cereals 20 m no-spray buffer with 20 m VFS

Winter cereals

20 m no-spray buffer with 20 m VFS

To protect aquatic organisms do not apply to artificially drained soils with clay content higher than or

equal to 45%

3.1.6.3 Effects on Bees and Other Arthropod Species

Effects on Honeybees

All hazard quotients for the formulated product PERSEO (SIP 40972), azoxystrobin and chlorothalonil are less than

50, indicating that the risk to bees is acceptable following use of PERSEO (SIP 40972) according to the proposed

use pattern.

Arthropods other than bees

The risk to non-target arthropods following exposure to PERSEO (SIP 40972) was addressed based on Tier II data

of the indicator species Aphidius rhopalosiphi, Typhlodromus pyri and Coccinella septempunctata in accordance

with the ESCORT 2 Guidance document (Candolfi et al 2000). The in-field and off-field foliar hazard quotients

were all below the trigger value for all proposed uses, indicating an acceptable risk.

3.1.6.4 Effects on Earthworms and Other Soil Macro-organisms

The risk to soil macroorganisms for the formulated product PERSEO (SIP 40972) was assessed according to the

SANCO guideline for terrestrial ecotoxicology (SANCO/10329/2002).

Page 16: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 16 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

For PERSEO (SIP 40972), azoxystrobin, chlorothalonil, and their metabolites, the TER values indicated an

acceptable acute and chronic risk to earthworms and other soil macroorganisms.

3.1.6.5 Effects on Soil Non-target Micro-organisms

The risk of PERSEO (SIP 40972) to soil micro-organisms was evaluated by comparison of no effect concentrations,

derived from laboratory tests, with PECS. All no effect levels exceed the relevant PECS values, indicating that the

risk to soil micro-organisms is acceptable following use of PERSEO (SIP 40972) according to the proposed use

pattern.

3.1.6.7 Assessment of Potential for Effects on Other Non-target Organisms (Flora and Fauna)

The risk to non-target plants for the formulated product PERSEO (SIP 40972) was assessed according to the

SANCO guideline (SANCO/10329/2002), using the endpoints from a vegetative vigour test on 6 species of non-

target plants with the product PERSEO (SIP 40972). This study showed no toxicity on non-target plants at the

application rate of 3360.0 g product/ha, equivalent to 3 L product/ha (maximum single rate proposed for the

product).

It is therefore possible to conclude that PERSEO (SIP 40972) poses no concern to terrestrial non target-plants

according to the proposed uses.

3.1.7 Efficacy

The product complies with the Uniform Principles.

Considering the data submitted:

- the level of efficacy of PERSEO (SIP 40972) is considered as satisfactory for all uses;

- the level of phytotoxicity of PERSEO (SIP 40972) is considered as negligible for all uses;

- the risks of negative impact on yield, quality, transformation processes, propagation, succeeding crops are

considered as negligible;

- the risk of negative impact on adjacent crops is considered as acceptable. However particular attention

should be paid to conditions of application of PERSEO (SIP 40972) near adjacent crops;

- There is a risk of resistance to azoxystrobine for the Pyrenophora teres of barley requiring a monitoring

and the realization of efficacy trials in situation of characterized resistance.

- Considering the generalization of resistance to strobilurine for Septoria tritici, the product should be

applied only on a complex of diseases on cereals. To avoid the development of resistance of Pyrenophora

teres to azoxystrobine, the number of application is limited to one application per crop cycle on barley.

Page 17: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 17 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

3.2 Conclusions arising from French assessment

Linked to intended uses, PECgw for the metabolite R417888 of chlorothalonil occur at levels exceeding those

mentioned in regulation EC 1107/2009 and guidance document SANCO 221/2000.

Taking into account the above assessment, an unacceptable risk of groundwater contamination cannot be excluded

and then an authorisation cannot be granted in France.

A copy of the decision issued can be found in Appendix 1 – Copy of the product Decision.

3.3 Substances of concern for national monitoring

No information stated.

3.4 Further information to permit a decision to be made or to support a review of the conditions and

restrictions associated with the authorisation

3.4.1 Post-authorisation monitoring

N/A: not registered in France

3.4.2 Post-authorisation data requirements

N/A: not registered in France

3.4.3 Label amendments

N/A: not registered in France

Page 18: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 18 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Appendix 1 – Copy of the French Decision

Page 19: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 19 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Page 20: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 20 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Page 21: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 21 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Page 22: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 22 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Appendix 2 – Copy of the draft product label as proposed by the applicant

Page 23: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 23 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Page 24: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 24 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Page 25: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 25 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Page 26: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 26 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Page 27: Registration Report Part A - anses.fr · The company Oxon Italia SpA has requested marketing authorisation in France for the product PERSEO (formulation ... SIP 40972 (PERSEO) Registration

Part A National Assessment - Country – FRANCE

SIP 40972 (PERSEO) Page 27 of 27

Registration Report – Southern Zone

Applicant: Oxon Italia SpA Evaluator: FRANCE Date: 2017-09-26

Appendix 3 – Letter(s) of Access

Parts of the letters of access have been removed for confidentiality reasons